Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2024-03-07 Fund Information / Fact…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
112年度存貨週轉率
Fund Information / Factsheet Classification · 90% confidence The document is very short (279 characters) and contains inventory turnover ratios and average sales days for two fiscal years (111 and 112). It appears to be a brief factual data snippet related to inventory metrics, without any narrative, financial statements, or detailed analysis. There is no indication of a full report or announcement of a report publication. The content resembles a brief fact sheet or summary of key financial metrics. Given the brevity and nature of the data, the best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company facts and financials.
2024-03-07 Chinese
112年度毛利率
Fund Information / Factsheet Classification · 90% confidence The document is very short (378 characters) and contains a brief financial summary table with annual revenue, cost, gross profit, and gross margin percentages for two years. It also includes a note about explaining significant changes in gross margin. There is no detailed financial statement, management discussion, or comprehensive report content. The document appears to be a brief financial data summary or a factsheet rather than a full annual or interim report. Given the brevity and nature of the content, it fits best as a Fund Information / Factsheet (FS) rather than a full Annual Report (10-K) or Interim Report (IR).
2024-03-07 Chinese
112年度營益分析
Interim / Quarterly Report Classification · 95% confidence The document contains quarterly and annual financial data including revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin for multiple fiscal years. The data is structured by fiscal periods such as first quarter, half-year, third quarter, and full year. This indicates it is a comprehensive financial report for periods shorter than a full fiscal year, consistent with an Interim / Quarterly Report. The document length is short (1038 characters), but it contains substantive financial data, not just an announcement or certification. Therefore, it is classified as an Interim / Quarterly Report (IR). FY 2023
2024-03-07 Chinese
112年第4季權益變動表
Annual Report Classification · 85% confidence The document contains detailed tables of consolidated equity changes, including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, and total equity attributable to the parent company and non-controlling interests. The data is presented for the current period (year 112 in the ROC calendar, corresponding to 2023) and the previous period (year 111, corresponding to 2022). The content is financial in nature, showing changes in equity accounts over the fiscal year, which is typical of a financial statement or part of an annual or interim report. The document length is 3856 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. The presence of detailed financial tables with comparative periods indicates this is part of a financial report rather than a simple announcement or regulatory filing. Given the nature of the data (equity changes) and the period covered (full year 2023), this aligns best with an Interim / Quarterly Report (IR) or Annual Report (10-K). However, since the data is for the full year 2023 (period 112), it is more consistent with an Annual Report (10-K) or a component thereof. The document does not explicitly state it is the full annual report but provides detailed financial data for the full fiscal year. Therefore, the best classification is Annual Report (10-K). FY 2023
2024-03-07 Chinese
112年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the fiscal year 2023 Q4 (112年第4季) and comparative data for 2022 (111年度). It includes comprehensive financial data such as net profit before tax, depreciation, amortization, changes in assets and liabilities, cash flows from operating, investing, and financing activities, and cash balances at the beginning and end of the period. The presence of substantive financial statements and detailed financial analysis for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2512 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). FY 2023
2024-03-07 Chinese
112年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial figures for the fourth quarter of the year 112 (Taiwan calendar year, corresponding to 2023). It includes revenue, costs, expenses, net income, and earnings per share data. The document is about 2064 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarterly period indicates this is an Interim / Quarterly Report rather than a brief earnings release or an announcement. There is no indication that this is a full annual report or a certification or a regulatory filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR). FY 2023
2024-03-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.